Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	20
Overall Study	STARTED	A4250 Low Dose	23
Overall Study	STARTED	A4250 High Dose	19
Overall Study	Received Treatment	Placebo	20
Overall Study	Received Treatment	A4250 Low Dose	23
Overall Study	Received Treatment	A4250 High Dose	19
Overall Study	COMPLETED	Placebo	15
Overall Study	COMPLETED	A4250 Low Dose	18
Overall Study	COMPLETED	A4250 High Dose	16
Overall Study	NOT COMPLETED	Placebo	5
Overall Study	NOT COMPLETED	A4250 Low Dose	5
Overall Study	NOT COMPLETED	A4250 High Dose	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03566238/flow